About Bolder Science

Our mission is to provide healthcare professionals with unbiased clinical research information, easily.

Currently, you can access the following clinical trials being conducted worldwide:

359,057 studies
in
219 countries
Clinical trial information and results are updated daily from ClinicalTrials.gov. The latest data update was conducted on 01/24/2021.
This website is for US healthcare professionals

Log In to Bolder Science

or

Don't have an account? Sign Up

Please enter your email address.

You will receive a link to create a new password via email.

Log In

Create an Account

or
(optional) ?

Welcome, !

Please complete the following 4 questions to ensure you receive the information that best suits your needs.

Clinical Trials of Interest

When I’m looking for information on clinical trials, I usually am interested in...

finding clinical trials in which to enroll my patients

Rarely Often

finding newly launched clinical trials (for all phases)

Rarely Often

updates on status changes for clinical trials

Rarely Often

pipeline molecules

Rarely Often

Drug Interventions

Enter up to 3 drug interventions you are currently interested in:

Clinical trial information and results are updated daily from ClinicalTrials.gov. The latest data update was conducted on 01/24/2021.

Social Experiences and Sleep Study

Clinicaltrials.gov identifier NCT03937973

Recruitment Status Recruiting

First Posted May 6, 2019

Last update posted July 22, 2019

Study Description

Brief summary:

This study will test the effect of race-based social rejection on polysomnography derived sleep outcomes and nocturnal cardiovascular psychophysiology in a sample of 80 African Americans and 80 Caucasian Americans. The investigators will test group differences on these outcomes as well as within subjects by testing impact of rejection compared to a non-rejection control night in the sleep laboratory.

  • Condition or Disease:Sleep
    Blood Pressure
  • Intervention/Treatment: Behavioral: Social rejection
  • Phase: N/A
Detailed Description

African Americans (AA) are disproportionally burdened by cardiovascular disease compared to Caucasian Americans (CA). Poor sleep, which is more common among AA, may serve as an important pathway in understanding these disparities. Race-based rejection has been cross-sectionally related to poor sleep and negative cardiovascular outcomes. To test the links between social experiences and sleep, participants will spend two nights in the sleep laboratory. One night will be a control night where participants complete low arousal tasks prior to bedtime. On a second night, the investigators will randomize 80 AA and 80 CA to either race-based social rejection (i.e., being rejected by an out-group member) or same-race social rejection prior to bedtime to test the causal influences of race-based rejection on objective sleep parameters, measured using polysomnography, and nocturnal cardiovascular functioning. The investigators will test group differences on these outcomes as well as within subjects by testing impact of rejection compared to a non-rejection control night in the sleep laboratory. The order of the control and rejection task night will be counterbalanced.

Study Design
  • Study Type: Interventional
  • Estimated Enrollment: 160 participants
  • Allocation: Randomized
  • Intervention Model: Factorial Assignment
  • Intervention Model Description: All participants will complete two nights in the sleep laboratory. One night will be a non-rejection control night. The other night will be a rejection task night. In this regard, African American and Caucasian American participants will be randomized to one of two conditions. All participants will be exposed to social rejection prior to bedtime; however, they will either be rejected by a person of their own race (in-group member) or a different race (out-group member)
  • Masking: Double (Participant, Outcomes Assessor)
  • Primary Purpose: Basic Science
  • Official Title: The Effects of Social Experiences on Sleep and Cardiovascular Functioning
  • Actual Study Start Date: April 2019
  • Estimated Primary Completion Date: June 2023
  • Estimated Study Completion Date: June 2023
Arms and interventions
Arm Intervention/treatment
Experimental: Social rejection by in-group
One hour prior to bed, participants will be exposed to a social rejection paradigm that includes a computerized ball-tossing game (Cyberball) and a speech task. Participants are made to believe that they are being rejected by someone of their own race/ethnicity (e.g., African American rejected by another African American).
Behavioral: Social rejection
Social rejection paradigm
Experimental: Social rejection by out-group
One hour prior to bed, participants will be exposed to a social rejection paradigm that includes a computerized ball-tossing game (Cyberball) and a speech task. Participants are made to believe that they are being rejected by someone not of their own race/ethnicity (e.g., Caucasian American rejected by another African American).
Behavioral: Social rejection
Social rejection paradigm
Outcome Measures
  • Primary Outcome Measures: 1. Change in sleep onset latency, as determined by polysomnography [ Time Frame: Assessed on the night of the social rejection task and compared to the control task night; it is anticipated that these nights will take place consecutively ]
    Sleep onset latency is the time (in minutes) from "lights out" in the sleepon the nights following the social rejection task and the control task laboratory to onset of sleep, as measured via polysomnography
  • Secondary Outcome Measures: 1. Change in minutes of wake after sleep onset (WASO), as determined by polysomnography [ Time Frame: Assessed on the night of the social rejection task and the night of the control task; it is anticipated that these nights will take place consecutively ]
    Number of minutes awake once sleep is initiated, measured via polysomnography on the nights following the social rejection task and the control task
  • 2. Change in total sleep time, as determined by polysomnography [ Time Frame: Assessed on the night of the social rejection task and the night of the control task; it is anticipated that these nights will take place consecutively ]
    Total number of minutes scored as sleep, measured via polysomnography on the nights following the social rejection task and the control task
  • 3. Change in pre-ejection period (PEP) in response to rejection task [ Time Frame: Baseline to Post-rejection task, anticipated average of 30 minutes ]
    Pre-ejection period is measured via impedance cardiography, averaged over a 5-minute baseline period and in the minutes during the rejection task
  • 4. Change in heart rate variability (HRV) in response to rejection task [ Time Frame: Baseline to Post-rejection task, anticipated average of 30 minutes ]
    Heart rate variability is measured via EKG, averaged over a 5-minute baseline period and in the minutes during the rejection task
  • 5. Change in nocturnal heart rate variability [ Time Frame: Assessed on the night of the social rejection task and the night of the control task; it is anticipated that these nights will take place consecutively ]
    Heart rate variability is measured via EKG, beginning at "lights out" and collected across the night following the rejection task and control task; it is anticipated that the two nights will occur consecutively.
  • 6. Change in nocturnal pre-ejection period [ Time Frame: Assessed on the night of the social rejection task and the night of the control task; it is anticipated that the two nights will occur consecutively ]
    Pre-ejection period will be measured by impedance cardiography, beginning at "lights out" and collected across the night following the rejection task and control task; it is anticipated that the two nights will occur consecutively.
Eligibility Criteria
  • Ages Eligible for Study: 18 to 62 Years (Adult)
  • Sexes Eligible for Study: All
  • Accepts Healthy Volunteers: Yes
Criteria

Inclusion Criteria:

- Age: 18 to 62 years old

- Self-identified as African American/Black or Caucasian American/White

- English speaking, able to provide consent

- Self-reported bedtime between 10PM and 12AM for 5/7 nights for the past 3 months
(stability to be confirmed by sleep diary and wrist actigraphy).

- Self-reported sleep duration between 6.5 and 8.5 hours for 5/7 nights for the last
month (duration to be confirmed by actigraphy and sleep diary)

Exclusion Criteria:

- Body mass index of 40 or above

- Participants at high risk for obstructive sleep apnea, based on "high risk" score from
the STOP-Bang.

- Medical or psychiatric condition, as assessed by self-report and clinical interview
that affect sleep and/or cardiovascular functioning, including doctor diagnosed
arrhythmia, hypertension, congestive heart failure, major depression, bipolar
disorder, post-traumatic stress disorder.

- Medication use that is likely to affect sleep and/or cardiovascular functioning,
including antidepressants, anxiolytic or soporific medication, and beta-blockers.

Contacts and Locations
Contacts

Contact: Sierra Semko 415-514-2586 sierra.semko@ucsf.edu

Locations

United States, California
University of California, San Francisco
San Francisco

Sponsors and Collaborators

University of California, San Francisco

National Heart, Lung, and Blood Institute (NHLBI)

Investigators

Principal Investigator: Aric A Prather, PhD University of California, San Francisco

More Information
  • Responsible Party: University of California, San Francisco
  • ClinicalTrials.gov Identifier: NCT03937973 History of Changes
  • Other Study ID Numbers: 18-24889, R01HL142051
  • First Posted: May 6, 2019 Key Record Dates
  • Last Update Posted: July 22, 2019
  • Last Verified: July 2019
  • Individual Participant
    Data (IPD) Sharing
    Statement:
  • Plan to Share IPD: Yes
  • Plan Description: Our plan is to make all processed data available at the conclusion of the study in line with NIH guidelines
  • Supporting Materials: Study Protocol, Statistical Analysis Plan (SAP), Analytic Code
  • Time Frame: All processed data should be available within 5 years of completion of the study
  • Access Criteria: Consistent with NIH guidelines
  • Studies a U.S. FDA-regulated Drug Product: No
  • Studies a U.S. FDA-regulated Device Product: No
  • Keywords provided by University of California, San Francisco: sleep
    heart
    stress